Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.3985 | 0.3985 |
Plasmodium vivax | unspecified product | 0.0042 | 0.1511 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 1 | 1 |
Trypanosoma brucei | citrate synthase, putative | 0.0042 | 0.1511 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.5389 | 0.5389 |
Plasmodium vivax | citrate synthase, mitochondrial precursor, putative | 0.0042 | 0.1511 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.5389 | 0.5389 |
Brugia malayi | hypothetical protein | 0.004 | 0.0649 | 0.0649 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.3985 | 0.3985 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0649 | 0.5 |
Trypanosoma cruzi | citrate synthase, putative | 0.0042 | 0.1511 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0649 | 0.0649 |
Loa Loa (eye worm) | citrate synthase | 0.0042 | 0.1511 | 0.1511 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.3985 | 0.3985 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.3985 | 0.3568 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.3985 | 0.3568 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 1 | 1 |
Plasmodium vivax | unspecified product | 0.0042 | 0.1511 | 0.5 |
Echinococcus granulosus | citrate synthase | 0.0042 | 0.1511 | 0.0922 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0649 | 0.5 |
Brugia malayi | TAR-binding protein | 0.007 | 1 | 1 |
Leishmania major | citrate synthase, putative | 0.0042 | 0.1511 | 0.5 |
Trypanosoma cruzi | citrate synthase, putative | 0.0042 | 0.1511 | 0.5 |
Echinococcus multilocularis | citrate synthase | 0.0042 | 0.1511 | 0.0922 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.3985 | 0.3568 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.5389 | 0.5389 |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 1 | 1 |
Leishmania major | citrate synthase, putative | 0.0042 | 0.1511 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 1 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.0649 | 0.0649 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 1 | 1 |
Toxoplasma gondii | citrate synthase I | 0.0042 | 0.1511 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.5389 | 0.5389 |
Echinococcus granulosus | tar DNA binding protein | 0.007 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.3985 | 0.3568 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0649 | 0.5 |
Plasmodium falciparum | citrate synthase, mitochondrial, putative | 0.0042 | 0.1511 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 1 | 1 |
Brugia malayi | Probable citrate synthase, mitochondrial precursor, putative | 0.0042 | 0.1511 | 0.1511 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.3985 | 0.3985 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0649 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.3985 | 0.3985 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 30 uM | The inhibition of KB cell growth was determined | ChEMBL. | 8071942 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.